Earnings calendar/BBIO
BridgeBio Pharma, Inc. (BBIO)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Oct 28, 2026
Consensus estimate row
EPS target
$-0.67
Street estimate
Revenue target
$267.3M
Street estimate
Trailing EPS (avg 4Q)
$-0.89
Beat rate last 4: 0%
Latest EPS YoY
+17.9%
vs 2025-08-05
Latest revenue YoY
+120.4%
How results look so far
Trailing revenue (avg 4Q)
$178.3M
Printed quarters
EPS beat rate (4Q)
0%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 10, 2026
EPS miss
EPS actual / est
$-0.78 / $-0.58
-35.5%
Revenue actual / est
$243.7M / $220.9M
+10.3%
Result
Below target
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/4/2026upcoming | $-0.57 | Pending | — | $267.3M | Pending | — |
| 10/29/2026upcoming | $-0.49 | Pending | — | $252.0M | Pending | — |
| 10/28/2026upcoming | $-0.67 | Pending | — | $267.3M | Pending | — |
| 8/10/2026 | $-0.58 | $-0.78 | -35.5% | $220.9M | $243.7M | +10.3% |
| 5/7/2026 | $-0.68 | $-0.84 | -23.7% | $178.1M | $194.5M | +9.2% |
| 5/5/2026upcoming | $-0.71 | Pending | — | $178.6M | Pending | — |
| 2/24/2026 | $-0.71 | $-1.00 | -40.2% | $146.8M | $154.2M | +5.0% |
| 2/19/2026upcoming | $-0.74 | Pending | — | — | Pending | — |
| 10/29/2025 | $-0.88 | $-0.95 | -8.0% | $148.2M | $120.7M | -18.5% |
| 8/5/2025 | $-0.83 | $-0.95 | -14.5% | $108.1M | $110.6M | +2.3% |
| 4/29/2025 | $-1.00 | $-0.88 | +12.0% | $68.4M | $116.6M | +70.5% |
| 2/20/2025 | $-1.09 | $-1.31 | -20.2% | $4.0M | $5.9M | +45.6% |
| 11/12/2024 | $-1.03 | $-0.86 | +16.5% | $67.3M | $2.7M | -95.9% |
| 8/1/2024 | $-1.09 | $-0.39 | +64.2% | $4.0M | $2.2M | -45.3% |
| 5/2/2024 | $-0.71 | $-0.20 | +71.8% | $7.3M | $211.1M | +2808.2% |
| 2/22/2024 | $-0.95 | $-0.96 | -1.1% | $6.2M | $1.7M | -72.0% |
| 11/2/2023 | $-0.86 | $-1.08 | -25.6% | $4.3M | $4.1M | -4.0% |
| 8/3/2023 | $-0.86 | $-0.98 | -14.0% | $3.0M | $1.6M | -45.1% |
| 5/4/2023 | $-0.84 | $-0.92 | -9.5% | $3.4M | $1.8M | -45.8% |
| 2/23/2023 | $-0.86 | $-0.87 | -1.2% | $4.5M | $1.9M | -58.7% |
Need BBIO data in your own agent or pipeline?
The earnings data on this page — report dates, consensus EPS/revenue estimates, actuals and surprise history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.